A detailed history of Retirement Group, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Retirement Group, LLC holds 1,500 shares of IOVA stock, worth $9,285. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,000 50.0%
Holding current value
$9,285
Previous $8,000 175.0%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$7.59 - $17.47 $3,795 - $8,735
500 Added 50.0%
1,500 $22,000
Q4 2023

Feb 14, 2024

BUY
$3.3 - $8.89 $3,300 - $8,890
1,000 New
1,000 $8,000
Q2 2023

Aug 15, 2023

BUY
$5.36 - $9.06 $5,360 - $9,060
1,000 New
1,000 $7,000
Q2 2022

Aug 04, 2022

SELL
$6.38 - $18.33 $26,158 - $75,153
-4,100 Reduced 94.25%
250 $3,000
Q1 2022

May 06, 2022

BUY
$12.38 - $19.1 $24,760 - $38,200
2,000 Added 85.11%
4,350 $72,000
Q4 2021

Feb 09, 2022

SELL
$16.55 - $27.63 $33,100 - $55,260
-2,000 Reduced 45.98%
2,350 $45,000
Q3 2021

Nov 16, 2021

BUY
$20.35 - $26.63 $2,035 - $2,663
100 Added 2.35%
4,350 $107,000
Q2 2021

Aug 17, 2021

BUY
$16.33 - $33.07 $4,082 - $8,267
250 Added 6.25%
4,250 $111,000
Q4 2020

Feb 22, 2021

SELL
$28.04 - $50.26 $1,402 - $2,513
-50 Reduced 1.23%
4,000 $185,000
Q3 2020

Nov 16, 2021

BUY
$27.75 - $36.3 $95,210 - $124,545
3,431 Added 554.28%
4,050 $133,000
Q3 2020

Sep 08, 2021

SELL
$27.75 - $36.3 $95,210 - $124,545
-3,431 Reduced 84.72%
619 $15,000
Q4 2019

Aug 30, 2021

BUY
$17.95 - $29.41 $72,697 - $119,110
4,050 New
4,050 $112,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $977M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.